Indirect treatment comparison of lanadelumab and a C1-esterase inhibitor in pediatric patients with hereditary angioedema
Aim: To compare the efficacy and safety of lanadelumab versus other approved long-term prophylaxis (LTP) treatments in patients with pediatric hereditary angioedema (HAE) aged <12 years. Materials & methods: A systematic literature review was conducted to identify studies of LTP in patients...
Saved in:
Main Authors: | Maureen Watt, Rachel Goldgrub, Mia Malmenas, Katrin Haeussler |
---|---|
Format: | Article |
Language: | English |
Published: |
Becaris Publishing Limited
2025-01-01
|
Series: | Journal of Comparative Effectiveness Research |
Subjects: | |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Personalized biological treatment with lanadelumab in a patient with recurrent attacks of hereditary angioedema
by: Artur Gęsicki, et al.
Published: (2024-08-01) -
Investigation of the correlation of C1 esterase inhibitor
levels and functions with attack severity and frequency
in hereditary angioedema
by: Fatma Arzu Akkuş, et al.
Published: (2024-06-01) -
The latest therapeutic reports on short-term and long-term prophylaxis in the treatment of hereditary angioedema
by: Maciej Kozłowski, et al.
Published: (2024-02-01) -
Abdominal attack in a patient with hereditary angioedema due to C1 inhibitor deficiency complicated by a perforated peptic ulcer
by: Piotr Obtulowicz, et al.
Published: (2024-02-01) -
Hereditary angioedema diagnosis evaluation score (HADES): A new clinical scoring system for predicting hereditary angioedema with C1 inhibitor deficiency
by: Ricardo Zwiener, MD, et al.
Published: (2025-05-01)